Stocks Weaker, Led by High-Beta Names
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Biotech Correction Nearing Support - Wells Fargo Survey (GILD) (CELG) (VRTX) (PCYC) (ITMN) (FPRX) (ARRY) (IBB)
March 26, 2014 10:24 AM EDTA survey of buyside investors suggested the biotech correction could find support soon, said Wells Fargo. Sentiment showed more downside may be likely but the sell off probably doesn't have much more steam.
"To gauge where sentiment lies following the recent biotech correction, we conducted a survey of investors. Based on the... More
